MedTrace Logo

EpiRetinal Membrane Peeling and Internal Limiting Membrane

NCT04802265 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-10-23

No results posted yet for this study

Summary

To study and compare visual acuity in patients undergoing removal of the epiretinal membrane with and without the removal of the internal limiting membrane at baseline versus 6 month.

Conditions

  • Epiretinal Membrane
  • Macular Pucker
  • Internal Limiting Membrane

Interventions

PROCEDURE

Epiretinal membrane surgery

The surgery consists of a 23 or 25-gauge pars plana vitrectomy (PPV). The surgery was performed peri-bulbar anesthesia and could be combined with phacoemulsification. An intraocular dye is used to well visualized and facilitate ERM peeling. The ILM is not actively peeled. A search for iatrogenic breaks is performed towards the end of the procedure. Areas suspicious for breaks are treated with cryotherapy or peripheral endolaser.

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Isabelle Sillaire · University Hospital, Clermont-Ferrand

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2021-08-01
Completion
2021-08-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802265 on ClinicalTrials.gov